Skip To Main Content
Claud M. Grigg on Muck Rack

Claud M. Grigg

As seen in: Science Magazine, OncLive
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Claud M.

Contact Claud M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

|
By Diego Chowell, Claud M. Grigg, Jeffrey Weber, Yorktown Heights
| Science Magazine Verified
Immunotherapy works by activating the patient's own immune system to fight cancer. For effective tumor killing, CD8+ T cells recognize tumor peptides presented by human leukocyte antigen class I (HLA-I) molecules. In humans, there are three major HLA-I genes (HLA-A, HLA-B, and HLA-C). Chowell et al. asked whether germline HLA-I genotype influences how T cells recognize tumor peptides and respond to checkpoint inhibitor immunotherapies (see the Perspective by Kvistborg and Yewdell).
Open in Who Shared Issue with article?

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

|
By Diego Chowell, Luc G. T. Morris, Claud M. Grigg, Jeffrey Weber
| Science Magazine Verified
Download and print this article for your personal scholarly, research, and educational use. Buy a single issue of Science for just $15 USD.
Open in Who Shared Issue with article?
See all 2 licensed articles (3 Total)